-
Biogen's Parkinson's Antibody Could Boost Prothena, RBC Says
Monday, July 20, 2015 - 10:54am | 330In a report published Sunday, RBC Capital Markets analyst Michael Yee discussed why it is an "incremental positive" that Biogen Inc (NASDAQ: BIIB)'s new Parkinson's antibody supports his positive thesis on Prothena Corporation PLC. Biogen began a Phase 1 study of its BIIB-054...